About Prolific Machines
Prolific Machines is a company based in United States founded in 2020 by Declan Jones, Deniz Kent, and Max Huisman. Prolific Machines has raised $55 million across 4 funding rounds from investors including Gates Foundation, SALT and Ki Tua Fund. Prolific Machines offers products and services including Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems. Prolific Machines operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter United States
- Founders Declan Jones, Deniz Kent, Max Huisman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prolific Machines, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$55 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Gates Foundation
& 32 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prolific Machines
Prolific Machines offers a comprehensive portfolio of products and services, including Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems.
Platform for precise light-based control of cellular functions in protein production.
Genetic constructs to control major cellular functions using light signals.
Systems for efficient light control in biomanufacturing processes.
People of Prolific Machines
Unlock access to complete
Funding Insights of Prolific Machines
Prolific Machines has successfully raised a total of $55M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prolific Machines
Prolific Machines has secured backing from 33 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Gates Foundation, SALT and Ki Tua Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ki Tua Fund is focused on investing in health-focused startups.
|
Locked | Locked | Locked | |
|
Climate solutions are advanced via venture capital and startup acceleration.
|
Locked | Locked | Locked | |
|
Mayfield is focused on AI innovation and venture capital investments.
|
Locked | Locked | Locked |
Investor details for Prolific Machines
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prolific Machines
Investment portfolio details for Prolific Machines
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prolific Machines
Detailed financials for Prolific Machines
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prolific Machines Comparisons
Peer comparison for Prolific Machines
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prolific Machines
Prolific Machines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
Detailed competitors of Prolific Machines
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prolific Machines
Complete news archive for Prolific Machines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prolific Machines
Prolific Machines was founded in 2020.
Prolific Machines is headquartered in United States.
Deniz Kent is the current CEO of Prolific Machines. They have also founded this company.
Prolific Machines is a funded company, having raised a total of $55M across 4 funding rounds to date.
Prolific Machines was founded in 2020 in the United States as a biotechnology firm. A photomolecular biology platform is developed and supplied to enable precise control over cellular functions. Light, bioengineering, hardware, and AI are integrated for applications in cultivated meat production, nutritional and therapeutic proteins, pharmaceuticals, and various bioproducts. Operations focus on advancing dynamic cellular manipulation within the biotech sector.
Prolific Machines's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Prolific Machines offers Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems.
Prolific Machines has 33 investors. Key investors include Gates Foundation, SALT, Ki Tua Fund, Breakthrough Energy, and Mayfield.